Helen E. Campbell, Jehan N. Karim, Aris T. Papageorghiou, Edward C. F. Wilson, Oliver Rivero-Arias
To assess the cost-effectiveness of modifying current antenatal screening by adding first trimester structural anomaly screening to standard of care second trimester anomaly screening.
通过在标准的妊娠中期异常筛查中增加妊娠早期结构异常筛查，来评估修改现行产前筛查的成本效益。
{"title":"Evaluating the Cost-Effectiveness of Antenatal Screening for Major Structural Anomalies During the First Trimester of Pregnancy: A Decision Model","authors":"Helen E. Campbell, Jehan N. Karim, Aris T. Papageorghiou, Edward C. F. Wilson, Oliver Rivero-Arias","doi":"10.1111/1471-0528.18053","DOIUrl":"https://doi.org/10.1111/1471-0528.18053","url":null,"abstract":"To assess the cost-effectiveness of modifying current antenatal screening by adding first trimester structural anomaly screening to standard of care second trimester anomaly screening.","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"107 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142991563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jennifer A. Jairam, Eyal Cohen, Christina Diong, Hilary K. Brown, Jun Guan, Howard Berger, Joel G. Ray
Conflicts of Interest
The authors declare no conflicts of interest.
利益冲突作者声明无利益冲突。
{"title":"Joint Effects of Maternal Comorbidity and Neighbourhood Income Mobility on the Ensuing Risk of Severe Maternal Morbidity","authors":"Jennifer A. Jairam, Eyal Cohen, Christina Diong, Hilary K. Brown, Jun Guan, Howard Berger, Joel G. Ray","doi":"10.1111/1471-0528.18078","DOIUrl":"https://doi.org/10.1111/1471-0528.18078","url":null,"abstract":"<h2> Conflicts of Interest</h2>\u0000<p>The authors declare no conflicts of interest.</p>","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"57 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142991564","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Relph Sophie Alexandra, Stirnemann Julien Josseph, Napolitano Raffaele
<p>There is a wide range of charts available for the assessment of estimated foetal weight (EFW) and measured neonatal weight centiles at a given gestational age. Charts vary in methodology, with descriptive and prescriptive, population and customised versions available, many designed with a high risk of bias [<span>1, 2</span>]. In many countries, including the UK, operators use varied charts for prenatal and neonatal care, leading to disagreement on diagnosis of abnormal growth. In determining which chart to apply in our tertiary centre and potentially nationwide, we aimed to identify a chart package that is applicable to our population, offers charts for assessment of EFW, actual birthweight and fundal height and is concordant with the UK-WHO birthweight charts recommended nationally by the Royal College of Paediatrics and Child Health (RCPCH—rcpch.ac.uk) which are based on British growth reference centiles derived by Cole in 1990 [<span>3</span>]. Such concordance should facilitate agreement on small or large sizes, including the presence of growth restriction, between obstetricians and neonatologists, improving continuity of care with regard to the risk of perinatal morbidity and mortality. The INTERGROWTH-21st package offers both foetal and neonatal charts and has previously shown good continuity of growth between prenatal and neonatal centiles at late pre-term and term gestations in these populations when EFW in grams was calculated using both their formula including head and abdominal circumference only, or the Hadlock's formula, using three parameters (head, abdominal circumference and femur length) [<span>4, 5</span>]. INTERGROWTH-21st prenatal chart centiles have also been shown to adequately fit the distribution of a large French prospective sample of ultrasound-derived foetal measurements [<span>6</span>]. Here, we describe work to evaluate whether the INTERGROWTH-21st birthweight centiles are concordant with those of the UK-WHO birthweight charts for pre-term and term births [<span>7</span>].</p> <p>We used 10th, 50th and 90th centile thresholds published by the INTERGROWTH-21st group for neonatal birthweight charts at each gestational day between 24 and 42 weeks to produce centile charts for male and female babies. UK-WHO birthweight centiles have only been published in chart format, from which it is difficult to derive the exact birthweight for the 10th, 50th and 90th centiles during each gestational day. We therefore produced a simulation data set, including male and female neonates with birthweights of 10-g increments between 400 and 5500 g, for each gestational day between 24 and 42 weeks. We calculated the UK-WHO birthweight centiles using the Stata ‘zanthro’ command (StataCorp LLC, Texas, USA). <i>Zanthro</i> is a user-written command that calculates z-scores for anthropometric measures according to reference growth charts, with a specific option to apply the Cole UK-WHO charts. We then converted z-scores into birthweight cen
{"title":"INTERGROWTH-21st Birthweight Charts Offer Excellent Concordance With UK-WHO Birthweight Charts Used by Neonatologists","authors":"Relph Sophie Alexandra, Stirnemann Julien Josseph, Napolitano Raffaele","doi":"10.1111/1471-0528.18048","DOIUrl":"https://doi.org/10.1111/1471-0528.18048","url":null,"abstract":"<p>There is a wide range of charts available for the assessment of estimated foetal weight (EFW) and measured neonatal weight centiles at a given gestational age. Charts vary in methodology, with descriptive and prescriptive, population and customised versions available, many designed with a high risk of bias [<span>1, 2</span>]. In many countries, including the UK, operators use varied charts for prenatal and neonatal care, leading to disagreement on diagnosis of abnormal growth. In determining which chart to apply in our tertiary centre and potentially nationwide, we aimed to identify a chart package that is applicable to our population, offers charts for assessment of EFW, actual birthweight and fundal height and is concordant with the UK-WHO birthweight charts recommended nationally by the Royal College of Paediatrics and Child Health (RCPCH—rcpch.ac.uk) which are based on British growth reference centiles derived by Cole in 1990 [<span>3</span>]. Such concordance should facilitate agreement on small or large sizes, including the presence of growth restriction, between obstetricians and neonatologists, improving continuity of care with regard to the risk of perinatal morbidity and mortality. The INTERGROWTH-21st package offers both foetal and neonatal charts and has previously shown good continuity of growth between prenatal and neonatal centiles at late pre-term and term gestations in these populations when EFW in grams was calculated using both their formula including head and abdominal circumference only, or the Hadlock's formula, using three parameters (head, abdominal circumference and femur length) [<span>4, 5</span>]. INTERGROWTH-21st prenatal chart centiles have also been shown to adequately fit the distribution of a large French prospective sample of ultrasound-derived foetal measurements [<span>6</span>]. Here, we describe work to evaluate whether the INTERGROWTH-21st birthweight centiles are concordant with those of the UK-WHO birthweight charts for pre-term and term births [<span>7</span>].</p>\u0000<p>We used 10th, 50th and 90th centile thresholds published by the INTERGROWTH-21st group for neonatal birthweight charts at each gestational day between 24 and 42 weeks to produce centile charts for male and female babies. UK-WHO birthweight centiles have only been published in chart format, from which it is difficult to derive the exact birthweight for the 10th, 50th and 90th centiles during each gestational day. We therefore produced a simulation data set, including male and female neonates with birthweights of 10-g increments between 400 and 5500 g, for each gestational day between 24 and 42 weeks. We calculated the UK-WHO birthweight centiles using the Stata ‘zanthro’ command (StataCorp LLC, Texas, USA). <i>Zanthro</i> is a user-written command that calculates z-scores for anthropometric measures according to reference growth charts, with a specific option to apply the Cole UK-WHO charts. We then converted z-scores into birthweight cen","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"62 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142990547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Majke H. D. Van Bommel, Miranda P. Steenbeek, Joanna Inthout, Tessa Van Garderen, Marline G. Harmsen, Marieke Arts‐De Jong, Angela H. E. M. Maas, Judith B. Prins, Johan Bulten, Helena C. Van Doorn, Marian J. E. Mourits, Rachel Tros, Ronald P. Zweemer, Katja N. Gaarenstroom, Brigitte F. M. Slangen, Monique M. A. Brood‐Van Zanten, M. Caroline Vos, Jurgen M. J. Piek, Luc R. C. W. van Lonkhuijzen, Mirjam J. A. Apperloo, Sjors F. P. J. Coppus, Nicoline Hoogerbrugge, Rosella P. M. G. Hermens, Joanne A. De Hullu
ObjectiveTo compare menopause‐related quality of life (QoL) after risk‐reducing salpingectomy (RRS) versus risk‐reducing salpingo‐oophorectomy (RRSO) until 3 years of post‐surgery.DesignA prospective study (TUBA study) with treatment allocation based on patients' preference. Data were collected pre‐surgery and at 3 months, 1 and 3 years of post‐surgery.SettingMulticentre prospective preference trial in thirteen hospitals in the Netherlands.PopulationBRCA1/2 pathogenic variant (PV) carriers aged 25–40 (BRCA1) or 25–45 (BRCA2), who were premenopausal, without a future child wish and without current (treatment for) malignancy.MethodsTreatment allocation was based on patients' preference: either RRS from the age of 25 years with delayed oophorectomy at the maximum age of 45 (BRCA1) or 50 (BRCA2), or RRSO between the ages of 35–40 (BRCA1) or 40–45 (BRCA2). After RRSO, hormone replacement therapy (HRT) was recommended, if not contraindicated. Primarily, menopause‐related QoL as measured with the Greene Climacteric Scale (GCS) was compared between the RRS and RRSO without HRT group. Secondarily, GSC‐scores of the RRS group were compared with the scores of the RRSO with HRT after surgery group. A higher GSC‐score reflects more climacteric symptoms.ResultsUntil April 2023, 410 participants had undergone RRS and 160 RRSO. The BRCA1/BRCA2 proportions were 51.4%/48.6%. The mean age at surgery (SD) was 37.9 (3.5) years. Participants 3 years after RRSO without HRT had a 4.3 (95% CI 2.1–6.5; p < 0.001) point higher increase in GCS‐score from baseline compared to those after RRS, while the difference was 7.9 (95% CI 5.9–9.8) and 8.5 (95% CI 6.5–10.5) points at 3 and 12 months, respectively. Among participants with HRT after surgery, the RRSO group had a 2.4 (95% CI 0.8–3.9; p = 0.002) point higher increase in GCS‐score from baseline compared to the RRS group.ConclusionsIn this multicentre preference trial, menopause‐related QoL was better after RRS than after RRSO, even with HRT after RRSO. Differences between arms were most pronounced until one‐year post‐surgery.
{"title":"Salpingectomy With Delayed Oophorectomy Versus Salpingo‐Oophorectomy in BRCA1/2 Carriers: Three‐Year Outcomes of a Prospective Preference Trial","authors":"Majke H. D. Van Bommel, Miranda P. Steenbeek, Joanna Inthout, Tessa Van Garderen, Marline G. Harmsen, Marieke Arts‐De Jong, Angela H. E. M. Maas, Judith B. Prins, Johan Bulten, Helena C. Van Doorn, Marian J. E. Mourits, Rachel Tros, Ronald P. Zweemer, Katja N. Gaarenstroom, Brigitte F. M. Slangen, Monique M. A. Brood‐Van Zanten, M. Caroline Vos, Jurgen M. J. Piek, Luc R. C. W. van Lonkhuijzen, Mirjam J. A. Apperloo, Sjors F. P. J. Coppus, Nicoline Hoogerbrugge, Rosella P. M. G. Hermens, Joanne A. De Hullu","doi":"10.1111/1471-0528.18075","DOIUrl":"https://doi.org/10.1111/1471-0528.18075","url":null,"abstract":"ObjectiveTo compare menopause‐related quality of life (QoL) after risk‐reducing salpingectomy (RRS) versus risk‐reducing salpingo‐oophorectomy (RRSO) until 3 years of post‐surgery.DesignA prospective study (TUBA study) with treatment allocation based on patients' preference. Data were collected pre‐surgery and at 3 months, 1 and 3 years of post‐surgery.SettingMulticentre prospective preference trial in thirteen hospitals in the Netherlands.Population<jats:italic>BRCA1/2</jats:italic> pathogenic variant (PV) carriers aged 25–40 (<jats:italic>BRCA1</jats:italic>) or 25–45 (<jats:italic>BRCA2</jats:italic>), who were premenopausal, without a future child wish and without current (treatment for) malignancy.MethodsTreatment allocation was based on patients' preference: either RRS from the age of 25 years with delayed oophorectomy at the maximum age of 45 (<jats:italic>BRCA1</jats:italic>) or 50 (<jats:italic>BRCA2</jats:italic>), or RRSO between the ages of 35–40 (<jats:italic>BRCA1</jats:italic>) or 40–45 (<jats:italic>BRCA2</jats:italic>). After RRSO, hormone replacement therapy (HRT) was recommended, if not contraindicated. Primarily, menopause‐related QoL as measured with the Greene Climacteric Scale (GCS) was compared between the RRS and RRSO without HRT group. Secondarily, GSC‐scores of the RRS group were compared with the scores of the RRSO with HRT after surgery group. A higher GSC‐score reflects more climacteric symptoms.ResultsUntil April 2023, 410 participants had undergone RRS and 160 RRSO. The <jats:italic>BRCA1/BRCA2</jats:italic> proportions were 51.4%/48.6%. The mean age at surgery (SD) was 37.9 (3.5) years. Participants 3 years after RRSO without HRT had a 4.3 (95% CI 2.1–6.5; <jats:italic>p</jats:italic> < 0.001) point higher increase in GCS‐score from baseline compared to those after RRS, while the difference was 7.9 (95% CI 5.9–9.8) and 8.5 (95% CI 6.5–10.5) points at 3 and 12 months, respectively. Among participants with HRT after surgery, the RRSO group had a 2.4 (95% CI 0.8–3.9; <jats:italic>p =</jats:italic> 0.002) point higher increase in GCS‐score from baseline compared to the RRS group.ConclusionsIn this multicentre preference trial, menopause‐related QoL was better after RRS than after RRSO, even with HRT after RRSO. Differences between arms were most pronounced until one‐year post‐surgery.","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"37 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142987604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Milla Juhantalo, Tuija Hautakangas, Outi Palomäki, Jukka Uotila
To study the effects of chorioamnionitis on uterine activity and to investigate associations between external and intrauterine monitoring methods and neonatal outcomes.
目的：研究绒毛膜羊膜炎对子宫活动的影响，探讨体外和宫内监测方法与新生儿结局的关系。
{"title":"Intrauterine Contraction Monitoring in Chorioamnionitis: A Secondary, Blinded Analysis of a Randomised Controlled Trial Cohort","authors":"Milla Juhantalo, Tuija Hautakangas, Outi Palomäki, Jukka Uotila","doi":"10.1111/1471-0528.18076","DOIUrl":"https://doi.org/10.1111/1471-0528.18076","url":null,"abstract":"To study the effects of chorioamnionitis on uterine activity and to investigate associations between external and intrauterine monitoring methods and neonatal outcomes.","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"80 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142987148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Predicting Preterm Birth: An Evolving Landscape","authors":"Caroline Fox, Andrew Shennan","doi":"10.1111/1471-0528.18067","DOIUrl":"https://doi.org/10.1111/1471-0528.18067","url":null,"abstract":"","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"34 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142974779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Refining Global Analysis of Female Breast and Gynaecologic Cancers: Suggestions for Enhanced Methodology and Data Update","authors":"Haojie Cai, Shanshan Cheng, Yu Wang","doi":"10.1111/1471-0528.18071","DOIUrl":"https://doi.org/10.1111/1471-0528.18071","url":null,"abstract":"Click on the article title to read more.","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"6 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142967908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Tong Zhu, Henrik Marschall, Karina E. Hansen, Andrew W. Horne, Lucky Saraswat, Krina T. Zondervan, Stacey A. Missmer, Lone Hummelshoj, Atilla Bokor, Camilla S. Østrup, Anna Melgaard, Dorte Rytter
To build consensus on most important symptoms and related consequences for use in questionnaires to characterise individuals with suspected and confirmed endometriosis in the general population.
{"title":"Consensus on Symptom Selection for Endometriosis Questionnaires: A Modified e-Delphi Study","authors":"Tong Zhu, Henrik Marschall, Karina E. Hansen, Andrew W. Horne, Lucky Saraswat, Krina T. Zondervan, Stacey A. Missmer, Lone Hummelshoj, Atilla Bokor, Camilla S. Østrup, Anna Melgaard, Dorte Rytter","doi":"10.1111/1471-0528.18066","DOIUrl":"https://doi.org/10.1111/1471-0528.18066","url":null,"abstract":"To build consensus on most important symptoms and related consequences for use in questionnaires to characterise individuals with suspected and confirmed endometriosis in the general population.","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"16 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142967909","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Maureen Makama, Annie R. A. McDougall, Jenny Cao, Kate Mills, Phi-Yen Nguyen, Roxanne Hastie, Anne Ammerdorffer, A. Metin Gülmezoglu, Joshua P. Vogel
Evidence suggests L-arginine may be effective at reducing pre-eclampsia and related outcomes. However, whether L-arginine can prevent or only treat pre-eclampsia, and thus the target population and timing of initiation, remains unknown.
{"title":"L-Arginine and L-Citrulline for Prevention and Treatment of Pre-Eclampsia: A Systematic Review and Meta-Analysis","authors":"Maureen Makama, Annie R. A. McDougall, Jenny Cao, Kate Mills, Phi-Yen Nguyen, Roxanne Hastie, Anne Ammerdorffer, A. Metin Gülmezoglu, Joshua P. Vogel","doi":"10.1111/1471-0528.18070","DOIUrl":"https://doi.org/10.1111/1471-0528.18070","url":null,"abstract":"Evidence suggests L-arginine may be effective at reducing pre-eclampsia and related outcomes. However, whether L-arginine can prevent or only treat pre-eclampsia, and thus the target population and timing of initiation, remains unknown.","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"9 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142967907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jing Wu, Ying Ju, Jie Dong, Hengde Zhang, Xifeng Xiao, Xiaohong Wang
To investigate the relationship between prolonged ovarian stimulation and neonatal outcomes after autologous fresh embryo transfer (fET).
探讨自体新鲜胚胎移植（fET）后卵巢刺激时间延长与新生儿结局的关系。
{"title":"Prolonged Ovarian Stimulation Does Not Worsen Neonatal Outcomes After Fresh Embryo Transfers","authors":"Jing Wu, Ying Ju, Jie Dong, Hengde Zhang, Xifeng Xiao, Xiaohong Wang","doi":"10.1111/1471-0528.18062","DOIUrl":"https://doi.org/10.1111/1471-0528.18062","url":null,"abstract":"To investigate the relationship between prolonged ovarian stimulation and neonatal outcomes after autologous fresh embryo transfer (fET).","PeriodicalId":8984,"journal":{"name":"BJOG: An International Journal of Obstetrics & Gynaecology","volume":"38 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142940075","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：